Grifols SA ADR GRFS
News
Grifols S.A. (GRFS) Admits Improper Accounting, Announces Restatements, Shares Decline Again – Hagens Berman
GigaGen Receives FDA Clearance of IND Application for Phase 1 Trial of Recombinant Polyclonal for HBV Treatment, GIGA-2339
Grifols receives expanded XEMBIFY® (immune globulin subcutaneous human-klhw) label in U.S., strengthening its Ig portfolio for patients
Troubled Spanish pharma company Grifols says it may go private for $6 billion
Trending: Grifols Founding Family, Brookfield Eye Takeover Bid for Spanish Drugmaker
Grifols Faces Delisting Bid From Founding Family and Brookfield
Grifols shares rebound after KPMG greenlights accounts in wake of short-seller's report
Grifols' shares plunge further on short-seller's new report
Grifols Shares Rise on $1.76 Billion Sale of 20% Stake in Shanghai RAAS to Pay Down Debt